Tech Innovation Should Drive Affordability

Why It Matters

Affordability pressures threaten patient access and provider margins; leveraging technology offers a scalable path to lower costs while improving outcomes, reshaping the competitive landscape of U.S. healthcare.

Key Takeaways

• 66% of HFMA respondents cite affordability as transformation driver
• One‑third of Americans cut spending to afford medical care
• Corewell uses tech to improve survival rates for breast, colorectal, lung cancers
• Technology‑enabled primary‑care reduces avoidable ER visits for vulnerable patients

Pulse Analysis

The United States faces an escalating affordability crisis, with a Gallup poll revealing that roughly 33% of adults have trimmed essential expenses to pay for medical care. This financial strain fuels medication non‑adherence, a behavior that drives billions of dollars in avoidable costs each year. As payers and providers grapple with shrinking margins, the urgency to find cost‑containment solutions has never been higher, positioning technology as a potential lever for systemic change.

Technology’s promise lies in its ability to streamline care pathways and deliver precision interventions at lower cost. Corewell Health, for example, deploys advanced analytics to enforce evidence‑based protocols for breast, colorectal, and lung cancers, aiming for five‑year survival rates that exceed national averages while curbing unnecessary spending. Simultaneously, the organization leverages telehealth and data‑driven care coordination to expand primary‑care access for high‑risk populations, reducing avoidable emergency department visits and aligning with the Triple Aim of better health, lower costs, and improved patient experience. Such initiatives illustrate how digital tools can simplify complex processes, eliminate waste, and create measurable financial benefits.

For the broader industry, the lesson is clear: incremental tech adoption is insufficient. Leaders must cultivate a culture that questions legacy workflows and embraces innovative models, from AI‑powered diagnostics to continuous, team‑based care delivery. By doing so, health systems can transition from reactive cost‑cutting to proactive value creation, ensuring sustainable affordability and positioning themselves competitively in a market where price transparency and patient outcomes increasingly drive choice. The convergence of financial pressure and technological capability makes this an inflection point for lasting transformation.